Wntresearch Ab
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.wntresearch.com
Clinical Trials
4
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer
Phase 2
Active, not recruiting
- Conditions
- Colon Cancer
- Interventions
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2022-12-09
- Lead Sponsor
- WntResearch AB
- Target Recruit Count
- 100
- Registration Number
- NCT03883802
- Locations
- 🇪🇸
Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain
Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients
Phase 1
Completed
- Conditions
- Metastatic Breast CancerMetastatic Colon CancerMetastatic Prostate Cancer
- Interventions
- First Posted Date
- 2016-01-14
- Last Posted Date
- 2018-12-28
- Lead Sponsor
- WntResearch AB
- Target Recruit Count
- 17
- Registration Number
- NCT02655952
- Locations
- 🇩🇰
Clinical Research Department, Oncology, Rigshospitalet, Copenhagen, Denmark
🇩🇰Onkologisk Afdeling R, Herlev Hospital, Herlev, Denmark
🇩🇰Odense University Hospital, Odense, Denmark
Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer
Phase 1
Completed
- Conditions
- Colorectal CancerProstate CancerMetastatic Breast Cancer
- Interventions
- First Posted Date
- 2013-12-24
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- WntResearch AB
- Target Recruit Count
- 31
- Registration Number
- NCT02020291
- Locations
- 🇩🇰
Oncology Department, Herlev Hospital, Herlev, Denmark
News
No news found